Strategic partnerships HLI actively pursues collaborations with biotech and AI leaders (Insilico Medicine, Longevity Escape Velocity Foundation, Alamar Biosciences) to co-develop AI models, proteomics services, and longevity research capabilities, presenting sales opportunities for advanced data analytics, biotech services, and integrated health insights offerings.

AI foundation focus The company is building AI-driven longevity and precision health solutions, including an AI foundation model for longevity science and an AI-powered precision sleep program, signaling opportunities to sell AI consulting, data processing capacity, and platform integration for health forecasting and personalized interventions.

Genomics data As a genomics-based health intelligence firm compiling large-scale whole genome, phenotype, and clinical data, HLI represents a strong customer for cloud computing, data storage, privacy-compliant analytics, and ML tooling to accelerate discoveries and clinical-grade insights.

Thought leadership With high-profile advisors and researchers (Geoffrey Hinton joining as Scientific Advisor) and collaborative research initiatives, there is an opportunity to engage in sponsored research, executive briefings, and joint education programs to deepen relationships with decision-makers.

Market positioning Operating in precision health and longevity, HLI targets mid-to-large biotech and healthtech players needing integrated genomics, proteomics, and AI-enabled insights, suggesting cross-sell opportunities for data partnerships, lab services, and frontend health analytics platforms.